Fund Holdings — Ally Bridge Group (NY) LLC

Total Portfolio Value:
$167.86M
Total Bought:
$72.22M
Total Sold:
$92.67M
Net Transaction:
-$20.45M
Notable People:
Slanix Paul T Alex
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Soleno Therapeutics Inc336,486286,162-50,324$14.40M$11.68M6.96%-$2.73M
Sarepta Therapeutics, Inc.(SRPT)073,500+73,500$0$11.61M6.92%+$11.61M
Geron Corporation(GERN)2,760,4972,736,663-23,834$9.11M$11.60M6.91%+$2.49M
Merus N V255,928174,844-81,084$11.52M$10.35M6.16%-$1.18M
Insmed Incorporated(INSM)250,000129,000-121,000$6.78M$8.64M5.15%+$1.86M
Legend Biotech CorporationADS(LEGN)0195,000+195,000$0$8.64M5.15%+$8.64M
Alumis Inc0618,750+618,750$0$8.23M4.90%+$8.23M
Blueprint Medicines Corp160,95075,638-85,312$15.27M$8.15M4.86%-$7.12M
Disc Medicine, Inc.(IRON)0166,500+166,500$0$7.50M4.47%+$7.50M
Day One Biopharmaceuticals I
COM
0536,095+536,095$0$7.39M4.40%+$7.39M
Mind Medicine Mindmed Inc1,001,452965,426-36,026$9.41M$6.96M4.15%-$2.45M
Xenon Pharmaceuticals Inc.(XENE)309,369169,369-140,000$13.32M$6.60M3.93%-$6.71M
Praxis Precision Medicines, Inc.(PRAX)159,486153,379-6,107$9.73M$6.34M3.78%-$3.39M
Kura Oncology, Inc.(KURA)365,044306,762-58,282$7.79M$6.32M3.76%-$1.47M
Avadel Pharmaceuticals Plc0430,245+430,245$0$6.05M3.60%+$6.05M
Longboard Pharmaceuticals In270,559218,981-51,578$5.84M$5.92M3.53%+$75.0K
CG Oncology, Inc.(CGON)320,378174,876-145,502$14.06M$5.52M3.29%-$8.54M
Jasper Therapeutics, Inc.(JSPR)289,943218,614-71,329$8.51M$4.96M2.96%-$3.55M
Trevi Therapeutics, Inc.(TRVI)01,474,926+1,474,926$0$4.40M2.62%+$4.40M
Tyra Biosciences, Inc.(TYRA)0264,660+264,660$0$4.23M2.52%+$4.23M
Perspective Therapeutics, Inc.(CATX)0396,242+396,242$0$3.95M2.35%+$3.95M
Black Diamond Therapeutics I0835,000+835,000$0$3.89M2.32%+$3.89M
Context Therapeutics Inc.(CNTX)725,9511,886,232+1,160,281$1.00M$3.78M2.25%+$2.78M
Climb Bio, Inc.(CLYM)0500,000+500,000$0$3.56M2.12%+$3.56M
Promis Neurosciences Inc1,059,5821,059,5820$2.02M$1.59M0.95%-$434.4K
Avadel Pharmaceuticals PlcADR547,0360-547,036$9.24M$0—-$9.24M
Dianthus Therapeutics, Inc.(DNTH)216,9680-216,968$6.51M$0—-$6.51M
Lyra Therapeutics Inc1,003,7410-1,003,741$6.24M$0—-$6.24M
Marinus Pharmaceuticals Inc394,7730-394,773$3.57M$0—-$3.57M
Mersana Therapeutics Inc801,4370-801,437$3.59M$0—-$3.59M
Olema Pharmaceuticals, Inc.(OLMA)559,0350-559,035$6.33M$0—-$6.33M
Rapt Therapeutics Inc420,0000-420,000$3.77M$0—-$3.77M
Verona Pharma PlcADS736,7380-736,738$11.85M$0—-$11.85M
Page 1 of 1
Ally Bridge Group (NY) LLC — 13F Holdings — Q2 2024 | TickerTrail